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Background: The use of vasoconstrictor can affect the dynamic indices to predict fluid responsiveness. We
investigate the effects of an increase of vascular tone on dynamic variables of fluid responsiveness in a rabbit
model of hemorrhage, and to examine the ability of the arterial pressure surrogates dynamic indices to track
systolic volume variation (SVV) during hypovolemia under increased vasomotor tone.
Methods: Eighteen anesthetized and mechanically ventilated rabbits were studied during normovolemia (BL) and
after blood progressive removal (15 mL/kg, BW). Other two sets of data were obtained during PHE infusion with
normovolemia (BL + PHE) and during hypovolemia (BW + PHE). We measured central venous and left ventricular
(LV) pressures and infra diaphragmatic aortic blood flow (AoF) and pressure. Pulse pressure variation (PPV), systolic
pressure variation (SPV) and SVV were estimated manually by the variation of beat-to-beat PP, SP and SV,
respectively. We also calculated PPVapnea as 100 × (PPmax-PPmin)/PP during apnea. The vasomotor tone was
estimated by total peripheral resistance (TPR =mean aortic pressure/mean AoF), dynamic arterial elastance
(Eadyn = PPV/SVV) and arterial compliance (C = SV/PP). We assessed LV preload by LV end-diastolic pressure (LVEDP).
We compared the trending abilities between SVV and pressure surrogate indices using four-quadrant plots and
polar plots.
Results: Baseline PPV, SPV, PPVapnea, and SVV increased significantly during hemorrhage, with a decrease of AoF
(P < 0.05). PHE induced significant TPR and Eadyn increase and C decrease in bled animals, and a further decrease in
AoF with a significant decrease of all dynamic indices. There was a significant correlation between SVV and PPV,
PPVapnea and SPV in normal vasomotor tone (r
2 ≥ 0.5). The concordance rate was 91%, 95% and 76% between SVV
and PPV, PPVapnea and SPV, respectively, in accordance with the polar plot analysis. During PHE infusion, there was
no correlation between SVV and its surrogates, and both four-quadrant plot and polar plot showed poor trending.
Conclusion: In this animal model of hemorrhage and increased vasomotor tone induced by phenylephrine the
ability of dynamic indices to predict fluid responsiveness seems to be impaired, masking the true fluid loss.
Moreover, the arterial pressure surrogates have not the reliable trending ability against SVV.
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Fluid resuscitation protocols to optimize preload and car-
diac output (CO) in patients undergoing high-risk surgery
decreased hospital length of stay and postoperative com-
plications [1,2]. While hypovolemia (under-resuscitation)
can result in organ hypoperfusion and ischemia, over-
resuscitation (inadequate fluid administration) can result
in pulmonary and interstitial edema and increase the mor-
bidity and mortality of critically ill patients [3,4].
Based on the heart-lung interplay during mechanical
ventilation, fluid optimization has changed from CO op-
timization (maximization) to monitor dynamic parameters
of volume responsiveness [5,6]. These indices monitor the
respiratory change in stroke volume (SV) or its surrogates,
such as pulse pressure or systolic pressure induced by
positive pressure ventilation (functional hemodynamic
monitoring) [6]. Cyclic change in intrathoracic blood vol-
ume, due to positive-pressure ventilation is the main de-
terminant of the observed SV variation (SVV) and pulse
pressure variation (PPV) during mechanical ventilation
[7]. The magnitude of the respiratory changes in the left
ventricular (LV) SV (SVV) or its arterial pressure surro-
gates (PPV, the PPV during apnea, -PPVapnea-, and the sys-
tolic pressure variation, -SPV-) is an indicator of preload
reserve [5,6,8-11]. The higher the pre-infusion value of the
dynamic indices, the more pronounced the increase in SV
in response to fluid administration will be [5]. The thresh-
old values of dynamic variables of fluid responsiveness
range from 10 to 15% and a change greater than 12 to
13% (cut-off values) is highly predictive of fluid respon-
siveness [6].
Several studies have shown excellent accuracy for these
dynamic indices under strict conditions [4,11]. However,
there are several confounders in routine clinical practice
that can significantly reduce the predictive value of SVV
and its surrogates of fluid responsiveness, including low
tidal volume, cardiac arrhythmias, automatic calculation
method, intra-abdominal hypertension, elevated positive
end-expiratory pressure and use of vasopressor drugs
[5,12]. Since vasoactive drugs alter arterial tone as well as
venous capacitance, their use in clinical practice may
affect the accuracy of functional preload indicators to as-
sess fluid responsiveness, especially those arterial pressure
surrogates. To date, available data are conflicting (either
in a controlled experimental study or a clinical study), de-
pending on the vasopressor drug (norepinephrine versus
phenylephrine), the device to estimate and track the SV
(pulse pressure contour versus doppler flowprobe) and
the study conditions (normovolemia versus hypovolemia,
hypertension versus hypotension) [13-18].
We hypothesized that the use of a vasoconstrictor drug
may attenuate the increase of dynamic indices (SVV, PPV,
SPV, PPVapnea) during hypovolemia. The first aim of this
study was to investigate the effects of an increase ofvascular tone on preload dynamic variables of fluid re-
sponsiveness in a rabbit model of hemorrhage. The sec-
ond aim was to examine the ability of the arterial pressure
surrogates dynamic indexes to track SVV changes during
hypovolemia under increased vasomotor tone.
Methods
This study was approved by the Institutional Animal
Care and Use Committee (CHEA, Facultad de Medicina,
Universidad de la República -http://www.chea.udelar.edu.
uy/). We rigidly performed all institutional protocols to
handle animals under experimentation according to Guide
for the Care and Use of Laboratory Animals (NIH Publi-
cation N° 85–23, revised 1996), prepared by the National
Academy of Sciences’ Institute for Laboratory Animal
Research.
Animal instrumentation
Eighteen female New Zealand rabbits (body weight 2.56 ±
0.56 kg) were premedicated with acepromazine (0.3 mg/kg
i.m.) and meperidine (10 mg/kg i.m.). Anesthesia was in-
duced with a bolus dose of midazolam (0.5 mg/kg i.v.)
given via an ear vein. We tracheotomized and mechanically
ventilated (Amadeus Hamilton Medical AG, Switzerland)
the animals via an endotracheal tube (ID 2.5 mm). The
ventilator was set in the volume controlled ventilation
mode with a tidal volume of 9 mL/kg, end-expiratory pres-
sure of 5 cmH2O, a respiratory rate 40 ± 8 breaths/min and
a FiO2 of 60%. Normocapnia, guided by capnography
(Datex Inst Corp CD-200-43-00, Helsinki, Finland) and
monitored by serial blood gas evaluation (ABL520, Radi-
ometer, Denmark), was achieved by adjusting the respira-
tory rate to maintain an end-tidal CO2 tension between
30–38 mm Hg. Heart rate/respiratory rate ratio was > 3.6.
We maintained the anesthesia with a continuous infusion
of midazolam (0.5-1 mg/kg/h) to achieve the least and con-
stant effect on peripheral resistance and rocuronium brom-
ide (0.6 mg/kg/h) to avoid spontaneous breathing effort.
Intravenous saline solution (NaCl 0.9%) was administered
at a rate of 7 mL/kg/h as maintenance requirements [19].
Normothermia was kept using a heating pad.
We placed a 4.5 F triple-lumen central venous catheter
(Paediatric Multicath 3-Vygon) in the left jugular vein
for measuring central venous pressure, blood withdrawal
and drug infusion. A 20-gauge catheter was placed into
the LV through the right common carotid to monitor LV
pressure. A non constricting ultrasonic perivascular flow
probe (2.5PSB-Series Flow probe, Transonic Systems
Inc., Ithaca, NY, USA) was positioned around the infra-
diaphragmatic aorta by a right lumbar incision by an
extra-peritoneum approach and connected to a Doppler
flowmeter (model T101, Transonic Systems Inc., Ithaca,
NY, USA) to measure instantaneous aortic flow. A fluid-
filled catheter (20-gauge) was advanced through the right
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distal to the flow probe to monitor systemic arterial
blood pressure. All pressure transducers (P23Db Gould
Statham) were zeroed to atmospheric pressure and kept
at the atrial level.
Experimental protocol
Once we completed the instrumentation, the animals were
allowed to stabilize for 30 min. Baseline measurements
including all the variables described previously were ob-
tained during normovolemia (BL). After BL measurement,
the vasomotor tone was increased by phenylephrine
infusion (Sigma, St. Louis, MO) during 30 min and a
second set of hemodynamic data were obtained (BL +
PHE). Taking into account the half-life of PHE, we
allowed 20 minutes period after stopping phenylephrine
infusion for the rabbits to return to baseline, then, blood
was progressively withdrawn by stepwise cumulative
volume of 5 mL/kg with a total of 15 mL/kg of body
weight (20% of volemia) and a third set of hemodynamic
measurements were obtained (BW). Finally, 30 min
after BW, a fourth set of data were obtained during PHE
administration (BW + PHE). We adjust the PHE infu-
sion rate in order to obtain an increase of the vasomotor
tone, maintaining mean arterial pressure around the
baseline value (isobaric analysis). This allowed us to
avoid an indirect effect of intravascular arterial pressure
on the viscoelastic properties of the arterial wall. Once
the experimental protocol was completed, the animals
were killed with intravenous potassium chloride under
deep anesthesia.
Data collection and analysis
All signals were monitored in real time and stored digit-
ally with a hardware and software specially designed in
our laboratory (SAMAY M16) at a sampling frequency
of 200 Hz. Hemodynamic data were taken at the end of
expiration with the ventilator turned off.
SV was derived offline from the integral of the systolic
portion of the aortic flow curve for each cardiac cycle
(Figure 1). The vasomotor tone was assessed by total arter-
ial peripheral resistance (TPR =mean aortic pressure/mean
aortic flow), arterial capacitance (C = SV/arterial pulse pres-
sure) [20], and dynamic arterial elastance (Eadyn = PPV/
SVV) [21]. LV preload was assessed by end-diastolic pres-
sure. The first derivative of LVP (dP/dt) was digitally ob-
tained in order to estimate LV contractility (maximum dP/
dt, dP/dtmax) and LV active diastolic function (minimum
dP/dt, dP/dtmin). All continuous values were averaged over
a 5-sec period. PPV, SVV and SPV were calculated offline.
The calculus was performed over three consecutive respira-
tory cycles including five heartbeats each. Dynamic indices
are defined by the relative difference in maximum and
minimum values for pulse pressure (PPmax/PPmin), systolicpressure (SPmax/SPmin), and SV (SVmax/SVmin) for PPV,
SPV, and SVV, respectively according to:
100  Qmax−Qminð Þ= Qmax þ Qminð Þ=2½ 
with Q= PP, SP, SV for PPV, SPV, and SVV, respectively
(Figure 1).
Finally, we measured the PP during apnea (PPapnea)
and used this value to calculate the PPVapnea as: 100 ×
(PPmax - PPmin)/ PPapnea [9].
Statistical analysis
Statistical comparisons were performed using statistics
software (SPSS for Windows Version 18.0; SPSS Inc.,
Chicago, IL). Normal distribution was tested with the
Kolmogorov–Smirnov test. All data are expressed as
mean ± SD. Before the start of the study, the number of
animals required was determined with a power analysis
according to previous data and the target difference. In
accordance with a standardized difference (target differ-
ence/standard deviation, 11/8) of 1.37, a sample size of
18 animals was calculated for a P value of 0.05 with a
power of 80% [22]. PPV, SVV, SPV and PPVapnea were
analyzed at the different experimental conditions using
one-way analysis of variance for repeated measurements
(ANOVA). Post-hoc testing was performed using the
Bonferroni test. The relationship between SVV and its
surrogates (PPV, PPVapnea, SPV) were examined using
Pearson correlations. A P value < 0.05 was considered
statistically significant.
We used four-quadrant scatter plots to compare the
concordance rate of SVV and the arterial pressure surro-
gates indexes (PPV, PPVapnea, SPV) during BL and BW
(without PHE, PHE-) and during PHE infusion (PHE+).
The concordance rate was defined as the percentage of
the number of data points that are in two of the four
quadrants of agreement (upper right and lower left). We
also performed a polar plot analysis to compare the
trending abilities between SVV and its pressure surro-
gates during PHE - and PHE+. Polar plots present the
data from a 4-quadrant plot in a similar format to a
Bland-Altman plot but with a radial distribution of data
points about a polar origin. It allows a narrower and
more selective band of agreement to be applied to the
data [23]. We calculated the mean angular bias which is
the average angle between all polar axes and polar data
points, and the radial limits of agreement which is the
radial sector containing 95% of the data points. The ac-
ceptance limits in the polar plot analysis were an angular
bias of less than ± 5° and radial limits of agreement of
less than ± 30°. Although there is no guidance on suit-
able exclusion zones, we applied an exclusion zone when
the percentage of change of SVV data was below 15%
(0.05) [24].
Figure 1 Raw data showing aortic pressure and flow in one rabbit after blood withdrawal. PP: pulse pressure, SV: stroke volume, Paw:
airway pressure, SVV: stroke volume variation, PPV: pulse pressure variation. Shaded areas represent the SV during expiration (SVmin) and
inspiration (SVmax), respectively. Dotted lines state the systolic portion of the aortic flow curve.
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Table 1 shows the changes in baseline hemodynamic
data during hemorrhage and PHE infusion. Mean doses
of PHE infusion during BL + PHE and BW+ PHE was
15 ± 2 mcg/kg/min. Hemorrhage (median blood volume
loss, 33 ± 7 mL, ≈15 mL/kg) induced a significant decrease
of AoF (P < 0.05), meanwhile systemic arterial pressure
(mean and pulse pressure), C, TPR and Eadyn did not show
a significant change.
Phenylephrine infusion induced significant increase in
vasomotor tone (Figure 2) and it also induced a further
decrease in aortic flow with a significant SV decrease
(P < 0.05) (Table 1). Mean and pulse arterial pressure,Table 1 Hemodynamic data during normovolemia (BL), norm
hypovolemia (BW) and hypovolemia with phenylephrine infu
BL B
SV (ml) 0.39 ± 0.04 0.
AoF (mL . min-1) 71 ± 18 5
HR (bpm) 214 ± 26 1
CVP (mm Hg) 3 ± 1
MAP (mm Hg) 76 ± 16
PAP (mm Hg) 38 ± 10
LVEDP (mm Hg) 4.7 ± 5.7 5
dP/dtmax (mm Hg . s-1) 1544 ± 456 17
dP/dtmin (mm Hg . s-1) −1802 ± 765 −1
*p < 0.05 vs BL.
AoF: Aortic flow; CVP: Central venous pressure; dP/dtmax and dP/dtmin: Maximum
ventricular end diastolic pressure; MAP and PAP: Mean and pulse aortic pressure, reand heart rate did not show significant changes. LV pre-
load (estimated by LV end-diastolic pressure) and the
maximum and minimum first derivative of LVP did not
change during either hemorrhage and PHE infusion.
Baseline PPV, SPV, PPVapnea, and SVV increased sig-
nificantly during hemorrhage (P < 0.05) (Table 2). How-
ever, after hemorrhage, PHE determined a decrease of all
dynamic indices (P < 0.05), returning to baseline values
(Table 2). There was a significant correlation between
SVV and PPV, PPVapnea and SPV during BL and BW
(without PHE infusion) (r2 ≥ 0.5). However, there was no
correlation between SVV and its pressure surrogates dur-
ing PHE infusion.ovolemia with phenylephrine infusion (BL + PHE),
sion (BW + PHE)
L + PHE BW BW+ PHE
27 ± 0.09 0.25 ± 0.08 0.19 ± 0.05*
1 ± 15* 53 ± 13* 39 ± 10*
98 ± 33 217 ± 33 201 ± 21
4 ± 1 3 ± 1 5 ± 1
77 ± 12 77 ± 16 81 ± 13
40 ± 15 32 ± 13 38 ± 13
.7 ± 5.3 5.1 ± 4.7 4.2 ± 4.2
80 ± 946 1897 ± 1027 1838 ± 899
789 ± 631 −1763 ± 989 −1787 ± 1014
and minimum first derivative of LVP, respectively; HR: Heart rate; LVEDP: Left
spectively; SV: Stroke volume.
Figure 2 Bar plot showing changes in arterial dynamic
elastance (Eadyn), total peripheral resistance (TPR), and systemic
compliance (C) between baseline and hemorrhage (PHE-) and
phenylephrine infusion (PHE+). * P < 0.05.
Table 3 Polar analysis data between SVV and PPV,
PPVapnea and SPV during experimental conditions
without phenylephrine (PHE-; BL and BW) and with







PPV 91 2.2 21
PHE- PPVapnea 95 −3.2 21
SPV 76 −4.1 26
PPV 56 2.9 29
PHE+ PPVapnea 53 −5.1 19
SPV 43 −14.1 26
PPV: Pulse pressure variation; PPVapnea: PPV using PP during apnea as
denominator; SVV: Stroke volume variation; SPV: Systolic pressure variation.
BL: Basal; BW: Blood withdrawal.
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examine the trending abilities of arterial pressure surro-
gate dynamic indices against SVV in normal and high
vasomotor tone. In the four-quadrant plot analysis, we
found that changes in PPV, PPVapnea and SPV were 91%,
95% and 76% concordant with SVV in normal vaso-
motor tone, and significantly decreased by phenyleph-
rine administration (56%, 53% and 43%, respectively)
(Table 3 and Figure 3).
The polar plot analysis showed that mean angular bias
was 2.2°, -3.2°, -4.1° (PHE-) and 2.9°, -5.1° and −14.1°
(PHE+), and the radial limits of agreement were 21°, 21°
and 26° (PHE-) and 29°, 19° and 26°, respectively (Table 3
and Figure 3).
Discussion
The results from this rabbit hemorrhage model demon-
strate that the infusion of phenylephrine (a pure α1-
receptor agonist) blunts the dynamic preload indexes
increase after bleeding. This effect is mainly due to an
acute increase of vasomotor tone (decrease of arterial
compliance and Eadyn and TPR increase) without any ap-
parent change of the effective intravascular volume. This
result may suggest the limitation of dynamic indexes inTable 2 Dynamic indices data during normovolemia (BL),
normovolemia with phenylephrine infusion (BL + PHE),
hypovolemia (BW) and hypovolemia with phenylephrine
infusion (BW + PHE)
BL BL + PHE BW BW+ PHE
SVV (%) 12 ± 6 10 ± 4 32 ± 9*§ 11 ± 5‡
PPV (%) 13 ± 6 12 ± 5 28 ± 10*§ 15 ± 7‡
SPV (%) 10 ± 4 7 ± 3 19 ± 5*§ 12 ± 5‡
PPVapnea (%) 12 ± 6 11 ± 4 21 ± 7
*§ 14 ± 6‡
*p < 0.05 vs BL, §p < 0.05 vs BL + PHE, ‡p < 0.05 vs BW.
PPV: Pulse pressure variation; PPVapnea: PPV using PP during apnea as
denominator; SVV: Stroke volume variation; SPV: Systolic pressure variation.predicting fluid responsiveness in routine clinical practice
during hypovolemia and vasopressor drug administration.
Several studies have shown that PPV, SPV and PPVap-
nea are able to predict fluid responsiveness as surrogates
of SVV [6,10,11]. Accordingly, in normal vasomotor tone
(BL and BW) all dynamic arterial pressure indices chan-
ged in the same direction. Therefore, SVV correlated with
its arterial pressure surrogates (Pearson's product moment
r > 0.7) and showed a high concordance rate (quadrant
plot analysis) and acceptable mean angular bias and radial
limits of agreement (polar plot), except with SPV. How-
ever, the concordant rate in four-quadrant plot analysis
was poor during PHE administration, and mean angular
bias was higher than that in normal vasomotor tone.
This means that the trending ability of the arterial pres-
sure surrogates against SVV was not acceptable during
hemorrhage under increased vasomotor tone.
In the present study, we used the gold standard refer-
ence method for CO measurement (ultrasonic flowp-
robe) that directly measures instantaneous aortic flow
with a high degree of precision (± 1% to 2%). Hence, we
could estimate SV and SVV with a high certainty, and
allowed us to use SVV as a reference functional dynamic
index [25]. Studies using technologies such as esophageal
Doppler or pulse contour analysis (calibrated or uncali-
brated) may be impacted by the device itself, decreasing
the precision of the measurement of CO [26,27]. Also, the
validity of algorithms using these devices to track actual
SV in patients with altered arterial stiffness has shown a
decrease of SVV for prediction of fluid responsiveness in
patients [26,27]. Furthermore, we estimated the dynamic
parameters manually and synchronized with the respira-
tory cycle which is highly accurate [5,6].
To date there are insufficient and contradictory data
on the effect of vasoconstrictor therapy on dynamic pre-
load indicators either in experimental and controlled con-
dition or clinical setting [13-18]. Nouira et al. [13] have
Figure 3 The four-quadrant plots and polar plots to examine the trending abilities of PPV against SVV under normal vasomotor tone
(PHE-) and under increase vasomotor tone (PHE+). Half-circle polar plots are shown with data transformed to positive directional data only.
We applied an exclusion zone when the percentage of change of data was below 15% (0.5). SVV: stroke volume variation, PPV: pulse pressure variation.
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crease in CO and SV during severe hypovolemia with a
concomitant decrease in PPV and SPV. They proposed
that both effects were related to the shift of blood from
unstressed to stressed blood volume. This is in accordance
to Renner et al. [14] data on an animal hemorrhage model.
However, on account of the global end-diastolic volume
(PiCCO) remained unchanged, they proposed the effects
of NE administration beyond shifting blood from un-
stressed to stressed blood volume. In an euvolemic model
of ventilated pigs, Kubitz et al. [15] found that both SPV
and PPV correlated with SVV (aortic Doppler flow probe).
However, the correlations between SVV and SPV and PPV
became weaker during the arterial pressure increase by
PHE infusion. In the clinical setting, Sakka et al. [16] found
that an increase in blood pressure reduces SVV signif-
icantly, without changing SPV in cardiac surgical patients.
Wajima et al. [17] found that in patients scheduled to
undergo elective surgery, induced hypertension (PHE) de-
crease SVV and induced hypotension (nitroglycerine) in-
creased SVV. On the contrary, Hadian et al. [18] proposed
that SVV and PPV may be used to guide fluid replacement
algorithms in cardiac surgical patients receiving vasoactivedrugs therapy. None of these studies analyzed in a separate
manner the direct effects of a pure vasopressor versus the
indirect effects of the change in arterial pressure on the ar-
terial wall viscoelastic properties.
We demonstrate that the ability of the dynamic in-
dexes to predict fluid responsiveness during hemorrhage
under an isobaric increase of vasomotor tone (TPR and
Eadyn increase and C decrease) induced by phenyleph-
rine administration (a pure α1-agonist) would not be ac-
ceptable. The increase of SVV and its surrogates after
bleeding was blunted under PHE infusion. The concomi-
tant significant decrease of SV could also influence on this
response. Arterial stiffness depends not only on intravas-
cular pressure but also on viscoelastic properties of the
vascular wall. The isobaric analysis (mean aortic pressures
remained stable during BW and BW+ PHE), avoids the
indirect effect of the arterial pressure on the viscoelastic
properties of the arterial wall [28]. Therefore, the signifi-
cant TPR increase (steady component of afterload) and C
decrease (pulsatile component of afterload) during BW+
PHE are secondary to a direct effect of PHE on the visco-
elastic properties of the arterial vascular wall. Accordingly,
the PPV/SVV ratio, a functional approach to arterial tone
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plain the absence of correlation and concordance rate be-
tween SVV and its surrogates during PHE infusion. The
presence of both effects (direct and indirect) on arterial
stiffness during vasoactive drugs therapy plus a central ef-
fect on the cardiac contractility by the use of α1 and β1
agonist (like NE), could explain some of the contradictory
data referred previously.
α1-agonists have the ability to both increase (by redu-
cing venous compliance, thus converting unstressed to
stressed blood volume and increasing preload) and de-
crease (primarily through increases in venous resistance)
CO [29]. The result is likely related to dose of the drug,
the reserve in unstressed blood volume and the initial
tone in the veins, all of which affect the recruitable
blood volume, a critical hemodynamic reserve that can-
not be measured by any monitoring device [30]. PHE
creates countervailing effects increasing the stressed
blood volume through the recruitment of unstressed vol-
ume in the reservoir compartment (which increase the ven-
ous return) and increasing the venous resistance through
the mean radius decrease in the large veins (which decrease
the venous return), concomitantly. Therefore, although
stimulation of α1-agonist receptors decreases venous cap-
acitance and may transiently increase venous return by re-
cruitment of unstressed to stressed blood volume, this gain
may be offset by the increase in venous resistance and after-
load [29,31]. Although we cannot discard a reduction of the
intrathoracic blood volume and/or the presence of right
ventricular dysfunction during PHE infusion secondary to
pulmonary hypertension, the non significant change of LV
end-diastolic pressure would support a predominant in-
crease of vasomotor tone.
Recently, Cannesson et al. demonstrated that the im-
pact of PHE bolus on CO is related to the position of
the heart on the Frank-Starling relationship and is dose
dependent. They observed that when LV is preload inde-
pendent, PHE induces a decrease in CO and viceversa,
when it is preload dependent, PHE boluses induce an in-
crease in CO [32]. On the contrary, our data showed
that PHE infusion induced a further decrease in aortic
flow with a significant SV decrease after blood withdrawal
compared with normovolemia (BL + PHE), secondary to a
significant increase of vasomotor tone and maintaining
the mean arterial pressure. Probably, the higher dose and
continuous infusion could explain the differences during
hypovolemia. Regarding the pleth variability index (PVI), a
non-invasive alternative to PPV and SVV, Monnet et al.
reported that the prediction of fluid responsiveness by
PVI is less reliable than invasive indexes in patients with
acute circulatory failure receiving norepinephrine [33].
During BW, mean arterial pressure (CO×TPR) and pulse
arterial pressure (SV/C) were maintained at the expense of
a CO and SV decrease, secondary to a 45% increase of TPRand 14% decrease of C, probable due to the sympathetic
modulation of the arterial tone. Accordingly, Monnet et al.
comparing patients with acute circulatory failure who re-
ceived a fluid challenge or in whom NE was introduced or
increased, showed that changes in pulse arterial pressure
could not be used for monitoring the effects of NE on CO
[34]. Natalini et al. also showed that arterial pressure did
not enable to predict the individual response to volume ad-
ministration in a cohort of hypotensive patients receiving
NE and dobutamine [35].
Study limitations
Although, the arterial pressure and flow signal are ac-
quired in the abdominal aorta, where the arterial wall
stiffness and reflection wave are higher than proximal
central aorta, we took the caution to obtain both mea-
surements at the same site. It is widely accepted that
peripheral pulse pressure depends mainly on SV and ar-
terial stiffness (1/compliance). In this regard, the absence
of pulse pressure changes during PHE with concomitant
SV decrease is related to concomitant decrease of arter-
ial compliance [36,37]. We only estimate the compliance
of the abdominal aorta, not including ascending and de-
scending aorta compliances. Nevertheless, because total
compliance of a system is the sum of the individual com-
pliances in series, the change of the abdominal aorta com-
pliance could be representative of the compliance of the
entire aorta [37].
Flow probe only measures descending aortic flow (about
70%) and excludes flow to the aortic arch vessels (30%). Al-
though the assumption of a constant diversion of blood
flow during PHE infusion may be violated, previous experi-
mental animal data suggest that phenylephrine increases
arteriolar resistance uniformly in the different vascular ter-
ritories [29]. This fact plus the measure of blood pressure
and flow at the same place could make the dynamic in-
dexes estimated at abdominal aorta representative of the
whole arterial circulation.
Although, the LV end-diastolic pressure maintenance
could rule out a significant shift blood from unstressed
to stressed blood volume, we cannot discard an increase
of pulmonary arterial pressure secondary to PHE infu-
sion, concomitantly [29].
Conclusions
All dynamic preload indicators (SVV, SPV, PPV and
PPVapnea) were significantly reduced by phenylephrine
during hemorrhage, mainly by increasing the vasomotor
tone. In this animal model of hemorrhage and increased
vasomotor tone induced by phenylephrine the ability of
dynamic indices to predict fluid responsiveness seems to
be impaired, masking the true fluid loss. Moreover, the
arterial pressure surrogates have not the reliable trending
ability against SVV measured by ultrasound flowprobe.
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aware that vasopressors can substantially reduce the abil-
ity of the dynamic indicators to predict fluid responsive-
ness, masking the effective intravascular volume deficit.
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